Publications by authors named "Mark Wansbrough-Jones"

Claim this Profile
C
Clinical epidemiology of Buruli ulcer disease in Ghana, 2006-2024.
Yaw Ampem Amoako, Bernadette Agbavor, Michael Frimpong, Abigail Agbanyo, Aloysius Dzigbordzi Loglo, Mark Wansbrough-Jones

Clin Exp Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial resistant bacteria isolated from Buruli ulcer lesions in Ghana.
Nancy Ackam, Charity Wiafe Akenten, Abigail Opoku Boadi, Abigail Agbanyo, Kabiru Mohammed Abass, Mark Wansbrough-Jones

PLoS Negl Trop Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved protocols for isolation of Mycobacterium ulcerans from clinical samples.
Bernadette Agbavor, Rejoice Agyeiwaa Arthur, Abigail Agbanyo, Dzifa Kofi Ahiatrogah, Charity Wiafe Akenten, Mark Wansbrough-Jones

BMC Microbiol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A composite subunit vaccine confers full protection against Buruli ulcer disease in the mouse footpad model of Mycobacterium ulcerans infection.
Justice Kofi Boakye-Appiah, Andy C Tran, Matthew J Paul, Peter Hart, Richard O Phillips, Mark Wansbrough-Jones

PLoS Negl Trop Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial diversity in Buruli ulcer lesions in Ghana.
Nancy Ackam, Abigail Opoku-Boadi, Bernadette Agbavor, Jonathan Kofi Adjei, Abigail Agbanyo, Mark Wansbrough-Jones

J Clin Tuberc Other Mycobact Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and microbiological predictors of healing in Buruli ulcer disease.
Bernadette Agbavor, Abigail Agbanyo, Aloysius Dzigbordi Loglo, Philemon Boasiako Antwi, Nancy Ackam, Mark Wansbrough-Jones

J Clin Tuberc Other Mycobact Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana.
Yaw Ampem Amoako, Aloysius Dzigbordi Loglo, Michael Frimpong, Bernadette Agbavor, Mohammed Kabiru Abass, Mark Wansbrough-Jones

BMC Infect Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Richard O Phillips, Jérôme Robert, Kabiru Mohamed Abass, William Thompson, Fred Stephen Sarfo, Mark Wansbrough-Jones

Lancet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load.
Michael Frimpong, Bernadette Agbavor, Mabel Sarpong Duah, Aloysius Loglo, Francisca N Sarpong, Mark Wansbrough-Jones

PLoS Negl Trop Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assay.
Michael Frimpong, Hubert Senanu Ahor, Ahmed Abd El Wahed, Bernadette Agbavor, Francisca Naana Sarpong, Mark Wansbrough-Jones

PLoS Negl Trop Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with infection.
Aloysius D Loglo, Michael Frimpong, Mabel Sarpong Duah, Fred Sarfo, Francisca N Sarpong, Mark Wansbrough-Jones

PeerJ· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.
Mabel Sarpong-Duah, Michael Frimpong, Marcus Beissner, Malkin Saar, Ken Laing, Mark Wansbrough-Jones

PLoS Negl Trop Dis· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana.
Justice K Boakye-Appiah, Alexis R Steinmetz, Peter Pupulampu, Stephen Ofori-Yirenkyi, Ishmael Tetteh, Mark Wansbrough-Jones

Int J Mycobacteriol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
Fred Stephen Sarfo, Richard Phillips, Mark Wansbrough-Jones, Rachel E Simmonds

Cell Microbiol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.
Fatoumata Niang, Fred S Sarfo, Michael Frimpong, Laure Guenin-Macé, Mark Wansbrough-Jones

Sci Rep· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography.
Anita Wadagni, Michael Frimpong, Delphin Mavinga Phanzu, Anthony Ablordey, Emmanuel Kacou, Mark Wansbrough-Jones

PLoS Negl Trop Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic diversity of PCR-positive, culture-negative and culture-positive Mycobacterium ulcerans isolated from Buruli ulcer patients in Ghana.
Heather Williamson, Richard Phillips, Stephen Sarfo, Mark Wansbrough-Jones, Pamela Small

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "compliance with antimicrobial therapy for buruli ulcer".
Richard O Phillips, Fred S Sarfo, Mohammed K Abass, Michael Frimpong, Edwin Ampadu, Mark Wansbrough-Jones

Antimicrob Agents Chemother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.
Richard O Phillips, Fred S Sarfo, Mohammed K Abass, Justice Abotsi, Tuah Wilson, Mark Wansbrough-Jones

Antimicrob Agents Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana.
Richard O Phillips, Michael Frimpong, Fred S Sarfo, Birte Kretschmer, Marcus Beissner, Mark Wansbrough-Jones

Emerg Infect Dis· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A severe case of Buruli ulcer disease with pleural effusions.
Fred S Sarfo, William Thompson, Richard O Phillips, Albert Paintsil, Mohammed K Abass, Mark H Wansbrough-Jones

PLoS Negl Trop Dis· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease.
Richard O Phillips, Fred S Sarfo, Jordi Landier, Reid Oldenburg, Michael Frimpong, Mark Wansbrough-Jones

PLoS Negl Trop Dis· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease.
Fred S Sarfo, Richard O Phillips, Jihui Zhang, Mohammed K Abass, Justice Abotsi, Mark H Wansbrough-Jones

BMC Infect Dis· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice.
Sandor Klis, Tjip S van der Werf, Richard O Phillips, Fred S Sarfo, Mark Wansbrough-Jones

AIDS· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
Fred Stephen Sarfo, Paul J Converse, Deepak V Almeida, Jihui Zhang, Clive Robinson, Mark Wansbrough-Jones

PLoS Negl Trop Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis